Are Chinese stocks and the broader emerging markets an attractive investment opportunity, or do they represent a value trap? This question becomes even more pressing given the divergent performances and economic signals emanating from China and other emerging economies.
The onset of 2023 brought with it high hopes from financial giants like Goldman Sachs, with strategists like Kinger Lau leading a chorus of Wall Street voices in predicting a robust rally in China's stock market.
Analysts speculated that the termination of China's stringent Covid-19 measures would catalyze a swift economic rebound.
However, as reported by Bloomberg, the anticipated economic resurgence took an unexpected turn. Contrary to the expected upswing, China's economy faced a downturn, with its stock market suffering a substantial 15% decline, marking a third consecutive year of downward trajectory.
The iShares China Large-Cap ETF (NYSE:FXI) has fallen 19%, on track for the lowest yearly close since 2008.
The Emerging Markets' Tale
In contrast to China's downturn, other emerging markets displayed remarkable resilience.
Excluding China, these markets, as tracked by the iShares MSCI Emerging Markets ex China ETF (NASDAQ:EMXC) have shown a robust 15% growth. This performance, especially in the face of challenges like the Fed's aggressive rate hikes and a robust dollar, underscores a crucial narrative – the decoupling of Chinese assets from the broader emerging markets.
Chinese Stocks Trade Cheap: Is It A Value Trap?
As a Wall Street Journal's recently showed, major U.S.-listed Chinese companies, like Alibaba Group Holding Ltd. (NYSE:BABA) and Tencent Music Entertainment Group (NYSE:TME), are trading at significantly lower price-to-earnings (P/E) ratios compared to their American counterparts, suggesting a possible undervaluation.
The forward P/E ratios for Alibaba, NetEase Inc. (NASDAQ:NTES), and JD.com Inc. (NASDAQ:JD) stand at 8 times, 12 times, and 9 times, respectively.
This contrast becomes starker when compared to the 'Magnificent Seven' tech giants in the U.S., trading at much higher ratios, close to 30 times their projected earnings.
Economic Outlook In China
Wall Street's perspectives on China's economic future are varied.
While some analysts remain optimistic, predicting a rebound driven by factors like government support in renewable energy, others are more cautious.
The prediction of a 4.8% growth in 2024 by Goldman Sachs, a dip from the previous year, adds to this mixed sentiment. Moreover, the contrasting forecasts from Goldman Sachs and Morgan Stanley for China's stock market in 2024 highlight the uncertainty and divergent opinions in the financial world.
The Specter of Japanification
A growing concern among analysts is the possibility of China experiencing a scenario akin to Japan's prolonged economic stagnation, exacerbated by demographic challenges and high corporate debt. While opinions vary on the validity of this comparison, it underscores the shifting sentiment around China's economic future.
中國股票和更廣泛的新興市場是有吸引力的投資機會,還是代表價值陷阱?鑑於中國和其他新興經濟體發出的表現和經濟信號各不相同,這個問題變得更加緊迫。
2023年的到來帶來了高盛等金融巨頭的厚望,劉金格等策略師帶領華爾街大聲疾呼,預測中國股市將強勁上漲。
分析師推測,中國嚴格的Covid-19措施的終止將促進經濟的迅速反彈。
但是,據彭博社報道,預期的經濟復甦發生了意想不到的轉變。與預期的上升相反,中國經濟面臨衰退,其股市大幅下跌了15%,標誌着連續第三年出現下行趨勢。
iShares中國大型股ETF(紐約證券交易所代碼:FXI)已下跌19%,有望創下2008年以來的最低年度收盤價。
新興市場的故事
與中國的衰退形成鮮明對比的是,其他新興市場表現出非凡的彈性。
除中國外,根據iShares MSCI新興市場(中國除外)ETF(納斯達克股票代碼:EMXC)的追蹤,這些市場均顯示出15%的強勁增長。這種表現,尤其是在面臨美聯儲激進加息和美元堅挺等挑戰的情況下,凸顯了一個至關重要的說法——中國資產與更廣泛的新興市場脫鉤。
中國股票交易便宜:這是價值陷阱嗎?
正如《華爾街日報》最近所顯示的那樣,主要在美國上市的中國公司,例如阿里巴巴集團控股有限公司(紐約證券交易所代碼:BABA)和騰訊音樂娛樂集團(紐約證券交易所代碼:TME),其市盈率(P/E)明顯低於美國同行,這表明估值可能被低估。
阿里巴巴、網易公司(納斯達克股票代碼:NTES)和京東公司(納斯達克股票代碼:JD)的遠期市盈率分別爲8倍、12倍和9倍。
與美國 “壯麗七強” 科技巨頭相比,這種對比變得更加明顯,它們的交易比率要高得多,接近其預期收益的30倍。
中國經濟展望
華爾街對中國經濟未來的看法各不相同。
儘管一些分析師仍然持樂觀態度,他們預測政府對可再生能源的支持等因素將推動反彈,但另一些分析師則更爲謹慎。
高盛預測2024年將增長4.8%,比上年有所下降,這加劇了這種喜憂參半的情緒。此外,高盛和摩根士丹利對2024年中國股市的對比預測凸顯了金融界的不確定性和意見分歧。
日本化的幽靈
分析師越來越擔心的是,中國可能出現類似於日本長期經濟停滯的情況,而人口挑戰和高企債務加劇了這種情況。儘管對這種比較的有效性有不同的看法,但它凸顯了人們對中國經濟未來的看法不斷變化。